HemoGenyx LLC is a biopharmaceutical company focused on developing innovative therapies for blood diseases like leukemia and lymphoma. By leveraging a special class of cells, they aim to increase the effectiveness of bone marrow transplants and eliminate the need for donors. Their technologies have the potential to revolutionize the current standard of care by improving the efficacy and safety of these transplants.